DE602005005518D1 - Omega-phenyloctanamide - Google Patents

Omega-phenyloctanamide

Info

Publication number
DE602005005518D1
DE602005005518D1 DE602005005518T DE602005005518T DE602005005518D1 DE 602005005518 D1 DE602005005518 D1 DE 602005005518D1 DE 602005005518 T DE602005005518 T DE 602005005518T DE 602005005518 T DE602005005518 T DE 602005005518T DE 602005005518 D1 DE602005005518 D1 DE 602005005518D1
Authority
DE
Germany
Prior art keywords
phenyloctanamide
omega
omega phenyloctanamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005005518T
Other languages
English (en)
Other versions
DE602005005518T2 (de
Inventor
Peter Herold
Stefan Stutz
Robert Mah
Vincenzo Tschinke
Christiane Marti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Speedel Experimenta AG
Original Assignee
Speedel Experimenta AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Speedel Experimenta AG filed Critical Speedel Experimenta AG
Publication of DE602005005518D1 publication Critical patent/DE602005005518D1/de
Application granted granted Critical
Publication of DE602005005518T2 publication Critical patent/DE602005005518T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
DE602005005518T 2004-12-10 2005-12-09 Omega-phenyloctanamide Active DE602005005518T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH204804 2004-12-10
CH20482004 2004-12-10
PCT/EP2005/056622 WO2006061426A1 (en) 2004-12-10 2005-12-09 ω-PHENYLOCTANAMIDES

Publications (2)

Publication Number Publication Date
DE602005005518D1 true DE602005005518D1 (de) 2008-04-30
DE602005005518T2 DE602005005518T2 (de) 2009-04-23

Family

ID=36088490

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005005518T Active DE602005005518T2 (de) 2004-12-10 2005-12-09 Omega-phenyloctanamide

Country Status (13)

Country Link
US (1) US7615664B2 (de)
EP (1) EP1819663B1 (de)
JP (1) JP2008523035A (de)
CN (1) CN101076511A (de)
AR (1) AR051990A1 (de)
AT (1) ATE389633T1 (de)
BR (1) BRPI0518998A2 (de)
CA (1) CA2590247A1 (de)
DE (1) DE602005005518T2 (de)
HK (1) HK1110065A1 (de)
IL (1) IL183770A0 (de)
TW (1) TW200631929A (de)
WO (1) WO2006061426A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0505969D0 (en) 2005-03-23 2005-04-27 Novartis Ag Organic compounds
BRPI0620736A2 (pt) 2005-12-30 2011-12-20 Novartis Ag compostos orgánicos
EP1872780A3 (de) * 2006-06-14 2008-04-30 Speedel Experimenta AG Omega-Phenyloctanamide als therapeutische Verbindungen
ES2541107T3 (es) 2007-06-25 2015-07-16 Novartis Ag Derivados de N5-(2-etoxietil)-N3-(2-piridinil)-3,5-piperidindicarboxamida para su uso como inhibidores de renina
DE102008009623A1 (de) 2008-02-18 2009-08-20 Kaltenbach & Voigt Gmbh Vorrichtung zum Betreiben eines elektrisch betriebenen medizinischen Instruments

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0021636B1 (de) * 1979-06-16 1982-12-01 Beecham Group Plc Sekundäre Amine, ihre Herstellung und Verwendung in pharmazeutischen Zusammensetzungen
US5659065A (en) * 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
DE60103545T2 (de) * 2000-07-25 2005-08-25 Speedel Pharma Ag Verfahren zur herstellung von substituierten octanoyl-amiden
US20030114389A1 (en) * 2001-11-13 2003-06-19 Webb Randy Lee Combination of organic compounds
WO2003103653A1 (en) * 2002-06-11 2003-12-18 Elan Pharmaceuticals, Inc. Methods of treating alzheimer's disease using aryl alkanoic acid amides
BRPI0417017A (pt) * 2003-11-26 2007-02-21 Novartis Ag compostos orgánicos
EP1577292A1 (de) * 2004-03-17 2005-09-21 Pfizer Limited Phenylaminoethanolderivate als Agonisten von beta2 Rezeptoren
US7851634B2 (en) * 2004-03-19 2010-12-14 Novartis Ag 5-amino 4-hydroxy-7-(1H-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
BRPI0507877A (pt) * 2004-03-23 2007-07-24 Pfizer derivados de formamida, composição farmacêutica, uso dos mesmos e combinação

Also Published As

Publication number Publication date
AR051990A1 (es) 2007-02-21
HK1110065A1 (en) 2008-07-04
US7615664B2 (en) 2009-11-10
IL183770A0 (en) 2007-09-20
TW200631929A (en) 2006-09-16
WO2006061426A1 (en) 2006-06-15
BRPI0518998A2 (pt) 2008-12-23
EP1819663A1 (de) 2007-08-22
CN101076511A (zh) 2007-11-21
ATE389633T1 (de) 2008-04-15
CA2590247A1 (en) 2006-06-15
DE602005005518T2 (de) 2009-04-23
US20080153902A1 (en) 2008-06-26
JP2008523035A (ja) 2008-07-03
EP1819663B1 (de) 2008-03-19

Similar Documents

Publication Publication Date Title
CY2019034I1 (el) 4-φαινυλαμινο-κιναζολιν-6-υλ-αμιδια
NO2015023I1 (no) Sekukinumab
DE502005005035D1 (de) Wischblatt
DE112005001624A5 (de) Brillengestell
DE602005012636D1 (de) Erung
ATE392425T1 (de) Thiazolyl-dihydro-indazole
ATE520680T1 (de) Hiv-hemmende 5-heterocyclylpyrimidine
DE602005023008D1 (de) Zugbetriebssteuersystem
DE602005009283D1 (de) Spreizbeleuchtungseinrichtung
DE502005004842D1 (de) Wischblatt
DE112005000809A5 (de) Wankstabilisierungseinrichtung
NO20052127D0 (no) Sentrifugeakselleratorsystem
DE502005002602D1 (de) Fahrzeugtemperiersystem
DE502004012213D1 (de) Flachdichtung
AT500198B8 (de) Ladewagen
DE602005005518D1 (de) Omega-phenyloctanamide
DE202004017327U1 (de) Fitnessrad
DE112005000794T5 (de) Urethanspritzpistolenanordnung
AT500249A3 (de) Scheibenegge
DE502005003159D1 (de) Kettenstichnähvorrichtung
DE502004001961D1 (de) Barikadenbrecher
DE602005006369D1 (de) Hochgeschwindigkeitsabtastgerät
DE112005002245A5 (de) Polymerdichtung
DE112005001019A5 (de) Kunststoffschraubverschlusskappe
ATA482004A (de) Tuba-dämpfer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition